Editorial
Is it still time for meta-analyses in operable esophageal cancers, or rather for a change of paradigm?
Abstract
Since the eighties, several generally small and powerless trials compared surgery alone with surgery preceded or followed by radiotherapy (RT), chemotherapy (CT) or radiochemotherapy (CRT) in esophageal cancer.